Health in the future: breast cancer vaccine
It's looking more and more promising as the successful animal-tested breast cancer vaccine moves on to human trials.
Vincent K. Tuohy, PhD, an immunologist and researcher in the department of immunology at the Cleveland Clinic's Lerner Research Institute, and his team, supported by the National Cancer Institute, have been studying "the possibility of a vaccine that would protect women from breast cancer."
On May 30, the American researchers published their findings in the online edition of the journal Nature Medicine (to appear in the print version on June 10), showing that a breast cancer vaccine to target women aged 40 and up and those with a high risk of the disease could be just a few years away.
"Most attempts at cancer vaccines have targeted viruses, or cancers that have already developed," said Joseph Crowe, MD, director of Cleveland Clinic's Breast Center.
The vaccine works very differently from the two US Food and Drug Administration (FDA) approved vaccines for both cervical- and lung-targeting viruses namely the human papillomavirus (HPV) and Hepatitis B respectively.
It is designed to target ?-lactalbumin, a protein present in most breast cancers and breast milk and should "rev up a woman's immune system to target ?-lactalbumin - thus stopping tumor formation - without damaging healthy breast tissue," according to a Lerner Research Institute announcement.
At the end of March, Swedish researchers had also found that "HAMLET" (Human ?-lactalbumin Made LEtal to Tumor cells) kills 40 different types of cancers and explained their findings to a Swedish national radio station, SR- Sveriges Radio.
"Dr. Tuohy is not a breast cancer researcher, he's an immunologist, so his approach is completely different - attacking the tumor before it can develop. It's a simple concept, yet one that has not been explored until now," added Crowe.
Human trials will begin in 2011 and the goal if successful is to vaccinate women over the age of 40 since breast cancer risk increases after 40 and avoid preventative mastectomies.
This breakthrough research taking place in the US, Europe and Singapore could quickly save numerous lives as HAMLET has also been tested on bladder cancer with current studies looking at skin cancer and brain tumors.
Full study, "An autoimmune-mediated strategy for prophylactic breast cancer vaccination": http://www.nature.com/nm/journal/vaop/ncurrent/full/nm.2161.html
Full study, "HAMLET Interacts with Lipid Membranes and Perturbs Their Structure and Integrity": http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0009384
Life & Style blogs
Plus live in a folly tower and Towcester growth
Plus how much you need to earn to rent in London, and new homes figures
Plus where The Apprentices live, house price growth outside London, and househunter numbers
The 10 Best Scotch Whiskies
Casualty in crisis: A&E - a service in meltdown
The myth of the modern dad exposed: New book claims men still won't sacrifice their careers for fatherhood
The experts' guide to summer: From getting fit for the beach to recreating that Olympic buzz
Obsessive compulsive hoarding: A serious health risk in store
- 1 Heading for America? Prepare for the longest US immigration queues ever
- 2 Notes from a small island: Is Sealand an independent 'micronation' or an illegal fortress?
- 3 You thought Ryanair's attendants had it bad? Wait 'til you hear about their pilots
- 4 'Swivel-gate': David Cameron goes to war with the press over 'swivel-eyed loons' slur
- 5 It’s official: thanks to Stephen Hawking's Israel boycott, anti-Semitism is no more
BMF is the UK’s biggest and best loved outdoor fitness classes
Find out what The Independent's resident travel expert has to say about one of the most beautiful small cities in the world
Win anything from gadgets to five-star holidays on our competitions and offers page.
£28000 - £31500 per annum + benefits: Randstad Education Newcastle: Permanent ...
£50000 - £58000 per annum + Benefits and Bonus: Progressive Recruitment: SAP F...
£30000 - £40000 per annum + BENS: Progressive Recruitment: Drupal Developer A ...
£45000 - £50000 per annum + bens: Progressive Recruitment: C# WEB DEVELOPER Le...